Risk stratification using the Merlin Assay (CP-GEP) in an independent cohort of 930 patients with clinical stage I/II melanoma who did not undergo sentinel lymph node biopsy

Amaral, Teresa; Chatziioannou, Eftychia; Nuebling, Alica; Nanz, Lena; Sinnberg, Tobias; Niessner, Heike; Arentsen, Tim; Ruiter, Romy; Dwarkasing, Jvalini; Eggermont, Alexander M.; Leiter, Ulrike; Flatz, Lukas; Forchhammer, Stephan

dc.contributor.author	Amaral, Teresa
dc.contributor.author	Chatziioannou, Eftychia
dc.contributor.author	Nuebling, Alica
dc.contributor.author	Nanz, Lena
dc.contributor.author	Sinnberg, Tobias
dc.contributor.author	Niessner, Heike
dc.contributor.author	Flatz, Lukas
dc.contributor.author	Forchhammer, Stephan
dc.contributor.author	Leiter-Stöppke, Ulrike
dc.date.accessioned	2025-09-29T06:30:32Z
dc.date.available	2025-09-29T06:30:32Z
dc.date.issued	2025
dc.identifier.issn	0959-8049
dc.identifier.uri	http://hdl.handle.net/10900/170375
dc.language.iso	en	de_DE
dc.publisher	London : Elsevier Sci Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.ejca.2025.115372	de_DE
dc.subject.ddc	610	de_DE
dc.title	Risk stratification using the Merlin Assay (CP-GEP) in an independent cohort of 930 patients with clinical stage I/II melanoma who did not undergo sentinel lymph node biopsy	de_DE
dc.type	Article	de_DE
utue.quellen.id	20250630000000_00807
utue.personen.roh	Amaral, Teresa
utue.personen.roh	Chatziioannou, Eftychia
utue.personen.roh	Nuebling, Alica
utue.personen.roh	Nanz, Lena
utue.personen.roh	Sinnberg, Tobias
utue.personen.roh	Niessner, Heike
utue.personen.roh	Arentsen, Tim
utue.personen.roh	Ruiter, Romy
utue.personen.roh	Dwarkasing, Jvalini
utue.personen.roh	Eggermont, Alexander M.
utue.personen.roh	Leiter, Ulrike
utue.personen.roh	Flatz, Lukas
utue.personen.roh	Forchhammer, Stephan
dcterms.isPartOf.ZSTitelID	European Journal of Cancer	de_DE
dcterms.isPartOf.ZS-Issue	Article 115372	de_DE
dcterms.isPartOf.ZS-Volume	220	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE